Skin Pigmentation (Dark Spot) Treatment

Patients often use the same words for very different pigment problems: “dark spots”, “sun damage”, “melasma”, “acne marks”.

From a distance, these concerns may all look like areas of skin that are darker than the surrounding tissue. Clinically, that similarity can be deceptive.

A well-defined solar lentigo caused by years of ultraviolet exposure behaves differently from melasma. A brown mark left behind after an inflammatory acne lesion behaves differently again. Freckles may be genetically determined and become more visible with sun exposure without representing a disease at all.

The treatment therefore cannot begin with the question, “Which laser removes pigmentation?”

It has to begin one step earlier: what type of pigment are we looking at, what is stimulating it, how deep is the pigment response, and is the lesion even appropriate for cosmetic treatment?

In pigmentation, choosing the wrong treatment can do more than under-deliver. Excessive inflammation can sometimes make the skin darker. That is why diagnosis is not the introduction to the treatment plan.

Diagnosis is the treatment plan.

Dark skin and dark spots are not the same biological problem

Melanin is normal and necessary. It is produced by melanocytes and contributes to the colour of our skin, hair and eyes while also playing a protective role in the skin’s response to ultraviolet radiation.

Hyperpigmentation occurs when melanin production or distribution becomes increased in a particular area. What matters clinically is why that happened.

Sometimes the trigger is cumulative ultraviolet exposure. Sometimes it is inflammation. Sometimes hormonal influences and genetic susceptibility are important. In other cases, the pattern of pigmentation deserves medical assessment before any aesthetic interpretation is made.

This is the first reason I avoid treating pigmentation as a simple question of removing colour. The pigment is often the visible endpoint of another biological process.

I do not treat brown colour first. I try to understand why the skin produced the brown colour.

If the trigger remains active, removing visible pigment may only create a temporary pause before it returns.

Solar lentigines behave differently from melasma

Sunspots, or solar lentigines, are usually relatively well-defined areas of pigmentation that develop on chronically sun-exposed skin. They are commonly seen on the face and hands and become more frequent as cumulative ultraviolet exposure increases.

When the diagnosis is clear, these lesions can respond well to appropriately selected pigment-directed treatments. The important point is that the pigment behaves relatively locally.

Melasma is different.

It tends to form broader, often symmetrical areas of brown or grey-brown pigmentation, commonly across the cheeks, forehead or upper lip. Genetics, ultraviolet exposure, visible light, hormonal influences and other biological factors can all contribute to its behaviour.

The melanocytes in melasma are not simply holding one isolated deposit of pigment that needs to be removed. The skin has an ongoing tendency to produce abnormal pigmentation under certain stimuli.

This is why I think the phrase “remove melasma” creates the wrong expectation. Melasma is more usefully understood as a condition that can often be improved and controlled but has a meaningful tendency to recur.

Melasma rewards restraint more than aggression

Patients with melasma often arrive after a frustrating treatment history.

A cream helped temporarily. A peel produced improvement and then the pigmentation returned. A stronger treatment made the skin red and, several weeks later, darker. Eventually the patient concludes that nothing works.

Sometimes the real problem is that the treatment strategy has repeatedly tried to overpower a biologically reactive condition.

Melasma does not necessarily reward the most aggressive intervention. Heat and inflammation can exacerbate pigmentation in susceptible patients. That means a treatment that is entirely appropriate for an isolated sunspot may be poorly suited to a patient whose melanocytes are already highly reactive.

I therefore prefer a long-horizon strategy: control the drivers, reduce pigment production where appropriate, protect the skin consistently and use procedures only when their expected benefit is greater than the inflammatory cost they create.

That approach may feel slower than trying to erase every visible patch at once.

It is also much more compatible with the biology of a recurrent pigment condition.

Post-inflammatory pigmentation tells me that inflammation came first

Post-inflammatory hyperpigmentation is another example of why the sequence matters.

The patient may notice dark marks after acne, eczema, trauma, an irritating cosmetic treatment or another inflammatory event. Once the active lesion settles, pigment remains behind and becomes the new concern.

If the inflammation is still ongoing, however, concentrating only on the remaining colour puts treatment in the wrong order.

Active acne can continue generating new marks. Dermatitis can continue stimulating melanocytes. An overtreated skin barrier can continue producing low-level inflammation while the patient simultaneously tries stronger acids or procedures to remove the pigmentation that inflammation created.

In that situation, the first pigment treatment may actually be controlling the inflammatory disease and restoring a more stable skin environment.

Once the trigger has settled, the residual pigmentation can be approached more rationally.

Not every brown spot belongs in an aesthetic clinic

This is a boundary I consider non-negotiable.

A lesion should not be treated cosmetically simply because the patient calls it a sunspot.

If a pigmented lesion is changing, behaving unusually, bleeding, developing irregular features or otherwise creating diagnostic concern, it needs appropriate medical evaluation before an aesthetic treatment is used to remove or obscure it.

The reason is straightforward: an aesthetic device should never destroy the visual evidence of a lesion that first needed diagnosis.

This is particularly important when a patient arrives specifically asking for laser removal of one changing spot. The treatment request does not establish what that lesion is.

Before I make a pigmented lesion less visible, I need to be comfortable that making it less visible is medically appropriate.

Cosmetics come after diagnostic safety, not before it.

Pigment depth changes what treatment can reasonably achieve

Not all pigment sits in the same part of the skin.

Some pigment is predominantly epidermal and therefore relatively accessible to treatments that influence surface turnover or pigment production. Other pigmentation has a deeper dermal component. Melasma can also be mixed.

This affects both treatment selection and expectation.

A superficial lesion may respond relatively quickly to an appropriate strategy. Deeper pigment can be more resistant and may require a longer period of management. A patient who expects one peel or one laser session to remove every shade of brown is therefore using a treatment timeline that may not match the biological location of the pigment.

I think this is another reason fixed treatment packages are unhelpful. The visible colour alone does not tell us how easily the pigment will respond.

Topical treatment is not the “weak” alternative to a procedure

In pigmentation medicine, topical treatment can be the central treatment rather than preparation for the “real” procedure.

Different topical agents can influence melanin production, cell turnover, inflammation and oxidative pathways. The appropriate choice depends on the type of pigmentation, the patient’s skin and medical context.

In melasma especially, a disciplined topical strategy and photoprotection may carry more long-term importance than repeatedly performing procedures.

This is where expectations need to change. A patient may understandably prefer one intervention that clears everything immediately. But a chronic pigment tendency usually needs control, not a single dramatic event.

A procedure can sometimes accelerate improvement. It does not remove the biological need for maintenance when the condition itself is recurrent.

Chemical peels work by creating controlled change, not by peeling pigment off like paint

Chemical peeling is often described in very mechanical language: remove the dark layer and reveal new skin underneath.

The biology is more nuanced.

A peel creates controlled chemical injury at a selected depth. This changes epidermal turnover and can help reduce certain forms of superficial pigmentation over time.

Depth matters because greater injury also means greater inflammatory potential.

In pigment-reactive skin, a more aggressive peel does not automatically produce a better pigment result. If inflammation becomes excessive, the procedure itself can become a trigger for post-inflammatory pigmentation.

I therefore think of peel strength as a dose, not as a measure of effectiveness.

The correct dose is the one that creates enough biological change for the target while remaining inside the skin’s ability to heal without generating a larger pigment response.

Laser selection begins with the pigment diagnosis, not the machine name

Lasers and other light- or energy-based systems can be effective for selected pigmentation because specific wavelengths and pulse characteristics can interact with melanin.

But “laser pigmentation treatment” is far too broad to describe one procedure.

The target, wavelength, pulse duration, fluence, skin type and depth of pigment all matter. A treatment designed to target a well-defined solar lentigo has a different risk–benefit profile from repeated energy treatment in melasma.

This is why a previous laser that worsened pigmentation does not necessarily prove that every energy-based treatment is inappropriate. It may mean that the diagnosis, device, parameters or treatment timing were mismatched.

It can also mean that the patient’s skin simply has a lower tolerance for inflammatory intervention than the original treatment plan assumed.

The useful lesson is not “laser is good” or “laser is bad”.

It is that technology follows diagnosis.

Darker skin does not mean “no treatment”; it means a different margin for error

Patients with medium and darker skin tones are sometimes given two equally unhelpful messages.

One is that pigment treatments are unsafe for them. The other is that modern technology makes skin tone irrelevant.

Neither is a useful clinical position.

Skin with more active melanin production can be more vulnerable to post-inflammatory hyperpigmentation after procedures. That changes the amount of inflammation I am willing to create and may change the device, parameters, preparation and recovery strategy.

It does not mean meaningful treatment is impossible.

It means the treatment has to respect the fact that the skin’s pigment system is more likely to respond to injury.

My objective is not simply to lighten the existing spot. It is to do so without asking the surrounding skin to produce a new one.

Sun protection is part of treatment, not advice given after treatment

There is almost no point in discussing pigmentation without discussing light exposure.

Ultraviolet radiation can stimulate pigment production and contribute to recurrence. In melasma, visible light can also be relevant, which is one reason broad-spectrum and, in appropriate patients, tinted photoprotection may form part of the management strategy.

The important point is behavioural rather than product-specific.

A pigmentation procedure may reduce visible colour over several sessions. If the biological trigger continues every day without adequate protection, the result is continually being challenged.

This is why sun protection is not a temporary restriction for the week after a peel.

It is part of maintaining the result.

A pigmentation treatment cannot outrun an active pigment trigger forever.

Summer does not create one universal rule

Patients frequently ask whether pigmentation treatment has to stop completely during summer.

I do not think one seasonal rule fits every treatment.

Some topical strategies and conservative management can continue year-round with appropriate photoprotection. More inflammatory procedures may need different timing, particularly when the patient has high unavoidable sun exposure or active tanning.

The relevant question is not the month printed on the calendar.

It is how much ultraviolet exposure the patient will realistically receive, what procedure is being considered and how pigment-reactive the skin is.

A patient who cannot avoid intense sun exposure immediately after an inflammatory treatment may simply have a poor treatment window.

Waiting for a better window can be more effective than trying to force treatment into an environment that works against it.

Successful pigmentation treatment does not always mean zero pigment

For an isolated sunspot, the visible endpoint can sometimes be quite dramatic.

For melasma, I define success differently.

The pigmentation may become lighter, more uniform and easier to control. The periods between flares may become longer. The patient may need much less camouflage. Maintenance may become simpler.

That is meaningful improvement.

If success is defined only as “the pigmentation can never return”, a chronic relapsing condition will eventually be described as treatment failure even when it has been well controlled for a long period.

I prefer an endpoint compatible with the biology.

Controlled is not the same as cured, but controlled can still be an excellent clinical outcome.

Maintenance is especially important when the trigger has not disappeared

A solar lentigo treated successfully may remain absent for a long period, but chronic sun exposure can still create new lesions elsewhere.

Melasma has an even clearer tendency to recur because the underlying susceptibility remains.

Post-inflammatory pigmentation can return if the inflammatory condition returns.

This is why I do not regard maintenance as evidence that the treatment “did not work”.

What matters is what is being maintained. If the condition has a persistent biological driver, maintenance is part of controlling that driver.

The maintenance plan may involve photoprotection, topical treatment, management of triggering skin disease and selected procedures when appropriate. It should not automatically mean repeating the strongest previous procedure at fixed intervals.

When pigmentation treatment makes sense to me

I am most comfortable treating pigmentation when the diagnosis is clear enough that I know which biological behaviour I am trying to modify.

An isolated sunspot, recurrent melasma and post-inflammatory hyperpigmentation may all be cosmetically bothersome, but their treatment plans should not look identical.

I also want the skin itself to be stable enough for the intervention we are considering. If there is uncontrolled inflammation, active tanning, barrier disruption or an uncertain pigmented lesion, treatment may need to wait or move into another specialty first.

There are also patients whose freckles or mild pigmentation are completely normal and who, after discussion, decide that they do not need treatment.

That is a valid outcome too.

The objective is not to create skin without pigment.

It is to identify abnormal or unwanted pigment accurately, treat it without destabilising the skin, and accept that some pigment conditions are managed through consistency rather than defeated through intensity.

Frequently asked questions

What causes dark spots on the face?

Common causes include cumulative ultraviolet exposure, inflammation after acne or other skin injury, and conditions such as melasma in which genetic, hormonal and environmental influences affect melanocyte activity. The pattern and history help determine which mechanism is most likely.

Is melasma the same as sunspots?

No. Solar lentigines are usually discrete lesions related to cumulative sun exposure. Melasma tends to form broader patches and behaves as a more chronic, relapse-prone pigment disorder. They should not automatically receive the same treatment.

Can melasma be cured permanently?

I would not promise permanent cure. Melasma can often be improved substantially and controlled well, but recurrence remains possible because the underlying tendency toward pigmentation does not necessarily disappear.

Why did a previous treatment make my pigmentation darker?

Inflammation itself can stimulate pigment production. A procedure that is too aggressive for the diagnosis or skin type can therefore provoke post-inflammatory pigmentation or worsen a reactive condition such as melasma. The exact cause needs individual assessment rather than assuming one technology is universally responsible.

Are lasers safe for pigmentation?

They can be very useful for selected pigment problems when the diagnosis, device and treatment parameters are appropriate. The risk–benefit balance changes significantly between an isolated sunspot, melasma and pigment-reactive skin.

Can darker skin tones be treated?

Yes, but the threshold for inflammation and post-treatment pigmentation requires particular attention. Treatment selection and settings should be adapted to the patient’s skin response rather than assuming the same protocol belongs on every skin tone.

Will sunscreen remove existing pigmentation?

Photoprotection is primarily used to reduce further stimulation and recurrence rather than physically erase established pigment. It is nevertheless one of the most important parts of maintaining a pigmentation result.

Can acne marks be treated before my acne is controlled?

I generally prefer to control active inflammatory acne first. Otherwise new inflammation continues creating new pigment while we are trying to remove the marks from previous lesions.

How many treatments will I need?

There is no universal number because sunspots, melasma and post-inflammatory pigmentation behave differently. The depth of pigment, skin type, treatment chosen and biological response all influence the course.

How do I know whether a brown spot is safe to treat cosmetically?

A lesion that is new, changing or clinically unusual should be medically evaluated before cosmetic removal. The purpose is to establish that we are dealing with a benign pigment problem before a procedure alters its appearance.

When would you recommend no pigmentation procedure?

I would postpone or avoid a cosmetic procedure when the diagnosis is uncertain, when active inflammation or tanning makes the skin unnecessarily reactive, when the expected benefit does not justify the pigment risk, or when the pigmentation is a normal feature the patient ultimately does not feel needs correction.